Manufacturing: Page 13
-
Courtesy of Eli Lilly
Lilly, Strateos open remote-controlled robotic research lab in San Diego
The lab, which is part of a $90 million investment Lilly made in its San Diego site two years ago, will be accessible to emerging drug discovery companies.
By Kristin Jensen • Jan. 9, 2020 -
Belgian CDMO Ardena gets new private equity owners
The U.K. group GHO Capital Partners bought Ardena, which has expanded in Europe via several acquisitions under the ownership of Mentha Capital.
By Ned Pagliarulo • Jan. 9, 2020 -
Charles River Labs to buy HemaCare for $380M, expanding in cell therapy
The contract researcher expects HemaCare will boost a cell therapy business that earns it about $100 million in annual revenue.
By Kristin Jensen • Dec. 19, 2019 -
Paratek wins US contract to develop anthrax treatment
A BARDA contract will provide Paratek with up to $285 million, some of which would go toward to acquiring the biotech's antibiotic for a national stockpile.
By Kristin Jensen • Dec. 19, 2019 -
Novartis still hasn't solved its CAR-T manufacturing issues
Lingering difficulties in making all Kymriah product to FDA specifications has meant Novartis can't always charge for the cell therapy. New data at ASH could help the pharma's case.
By Ned Pagliarulo • Dec. 11, 2019 -
Novartis partners with Amazon to revamp manufacturing
The collaboration is one of many efforts underway at the Swiss pharma to more effectively manage a sprawling network of clinical and manufacturing sites.
By Kristin Jensen • Dec. 5, 2019 -
Thermo Fisher opens $90M viral vector manufacturing plant in Massachusetts
The CDMO expects to create more than 200 jobs at the site, which is part of the company's plans to expand its gene therapy business.
By Kristin Jensen • Dec. 4, 2019 -
Fujifilm to invest $120M in gene therapy, build center in Texas
The Japan-based company plans to spend $55 million on the center while also outfitting its joint venture with new clean rooms and bioreactors.
By Kristin Jensen • Nov. 21, 2019 -
Courtesy of Eli Lilly
Lilly to invest $400M in Indianapolis manufacturing facilities
The drugmaker expects its investment to create 100 new, highly skilled jobs based in Indianapolis.
By Kristin Jensen • Nov. 20, 2019 -
Lonza CEO Funk to step down after 9 months on job
Funk is leaving for personal reasons, Lonza reported in a brief statement, and will be replaced on an interim basis by chairman Albert Baehny.
By Kristin Jensen • Nov. 14, 2019 -
Jacob Bell/BioPharma Dive
Mylan plant warned by FDA over valsartan manufacturing
Regulators said Mylan's ways of identifying, testing and handling raw materials at an Indian plant aren't enough to prevent contamination.
By Kristin Jensen • Nov. 14, 2019 -
Teva to restart production of cancer drug after shortages stressed treatment
Vincristine, a drug used to treat childhood cancers, has been in short supply since Teva stopped producing it and manufacturing woes hit Pfizer, the sole other supplier.
By Ned Pagliarulo • Nov. 14, 2019 -
What pharma manufacturing can learn from M&Ms
As pharmaceuticals companies look to shift from batch to continuous production, manufacturers may take a page from the food industry's playbook.
By Gary Wollenhaupt • Nov. 12, 2019 -
Sanofi cuts chemical, water use in switch to continuous manufacturing
While the pharma industry had been slow to adopt continuous manufacturing, Sanofi's new plant in Framingham, Massachusetts, is one example of the benefits possible.
By Matt Leonard • Nov. 12, 2019 -
Takeda opens vaccine plant as dengue shot shows promise
A site in Germany will produce Takeda's dengue vaccine, newly supported by data that appears to show the drug as effective in protecting against the virus.
By Kristin Jensen • Nov. 7, 2019 -
Lonza taps Cryoport to bolster cell and gene therapy delivery
The Swiss manufacturer inked a deal with the cold chain specialist, which works with sector leaders like Gilead, Novartis and Bluebird bio.
By Kristin Jensen • Nov. 7, 2019 -
7 questions about ethylene oxide as FDA panel convenes
Agency advisers met again Thursday, having already encouraged the FDA to incentivize lower industry reliance on the controversial chemical.
By David Lim • Updated Nov. 7, 2019 -
Merck again borrows Gardasil supplies from CDC
Tapping the CDC's stockpile will lower sales of the HPV vaccine by about $120 million in the fourth quarter, Merck said.
By Kristin Jensen • Oct. 31, 2019 -
Jacob Bell/BioPharma Dive
FDA blames market failures for drug shortages
High-profile shortages of drugs like EpiPen and the chemotherapy vincristine have brought attention to a chronic problem, one that's spurred in part by what the FDA termed a "broken marketplace."
By Kristin Jensen • Oct. 31, 2019 -
BD suspends sterilization plant after FDA warning on device shortages
Public health concerns tied to ethylene oxide, a chemical used on half of medical devices requiring sterilization, have jeopardized sterilization facilities and the products they process.
By Maria Rachal • Oct. 28, 2019 -
Bluebird gets European green light for gene therapy production
Although Bluebird won EU approval for Zynteglo in June, the biotech delayed launching the one-time treatment to finalize manufacturing specifications.
By Kristin Jensen • Oct. 24, 2019 -
GSK hands 2 of its less profitable vaccines to Bavarian Nordic
The deal, worth about $335 million upfront, will help GSK simplify its supply chain and allow it to reinvest in higher growth areas, according to the company.
By Jacob Bell • Oct. 21, 2019 -
FDA warns losartan manufacturer of violations at Indian plant
The agency faulted Torrent Pharmaceuticals' executive oversight in a warning letter issued after the company voluntarily recalled lots of the antihypertensive.
By Kristin Jensen • Oct. 17, 2019 -
Courtesy of Sanofi
Sanofi upgrades biotech manufacturing with new Massachusetts plant
The French pharma has spent about $320 million over the past five years on the facility, part of a broader effort to retool how it makes the drugs it sells.
By Andrew Dunn • Oct. 15, 2019 -
Lilly shuttering UK neuroscience research site
Most employees will be relocated to a new facility in the area, although Lilly expects to lay off as many as 80 workers.
By Jonathan Gardner • Oct. 15, 2019
Previous
